Nature Reviews Cancer Submission Process
Nature Reviews Cancer's submission process, first-decision timing, and the editorial checks that matter before peer review begins.
Readiness scan
Before you submit to Nature Reviews Cancer, pressure-test the manuscript.
Run the Free Readiness Scan to catch the issues most likely to stop the paper before peer review.
How to approach Nature Reviews Cancer
Use the submission guide like a working checklist. The goal is to make fit, package completeness, and cover-letter framing obvious before you open the portal.
Stage | What to check |
|---|---|
1. Scope | Pre-submission editor inquiry (essential for unsolicited) |
2. Package | Manuscript preparation |
3. Cover letter | Submission via Nature system |
4. Final check | Editorial screening |
Quick answer: how to submit to Nature Reviews Cancer
The Nature Reviews Cancer submission process is not a standard original-research workflow. The journal mainly handles commissioned or editor-led review content, so the real gate is whether the editorial team believes the topic, author team, and proposed synthesis belong in the journal before a full manuscript is seriously considered.
That means the practical process is:
- establish whether the review idea is genuinely aligned with the journal
- present a strong concept or proposal, often before a full article matters
- show authority, synthesis depth, and clinical or translational relevance
- move into editorial review and then peer review only if the concept clears that first screen
For most authors, the hardest part is not the portal. It is proving that the proposed review is substantial enough, current enough, and important enough for a top oncology review journal.
Before you open the submission portal
Before you think about files or forms, check whether you can answer these questions clearly:
- Is this topic broad and consequential enough for a top oncology review journal?
- Does the manuscript synthesize a field, not just summarize recent papers?
- Can the author team credibly lead this conversation?
- Does the article connect mechanism, therapeutic implications, and future directions?
- Is there a sharper fit for another review outlet if the scope is narrower?
For Nature Reviews Cancer, a weak fit is usually obvious early. If the review is too narrow, too descriptive, or too disconnected from clinical significance, the process tends to stop before the manuscript gets real momentum.
It also helps to decide what kind of proposal you are really making:
- a major field synthesis
- a focused conceptual review with strong translational stakes
- a perspective on an emerging cancer mechanism or therapeutic direction
If you cannot define that clearly, the editorial read will probably feel uncertain too.
Step-by-step submission flow
1. Clarify whether the journal is realistically accessible
For many authors, the honest first step is checking whether Nature Reviews Cancer is a realistic target at all. Because the journal is highly selective and largely invitation-driven, authors often need to begin from editorial fit and author authority, not from routine submission momentum.
2. Prepare the concept, not just the manuscript
The strongest route usually starts with a clear proposal:
- what the review will cover
- why now is the right moment for it
- what competing models or literatures will be synthesized
- why the conclusions matter for cancer biology or therapy
If the concept is weak, a polished full draft rarely rescues the process.
3. Build a manuscript that reads like field leadership
Once the article is under consideration, the manuscript has to feel authoritative immediately. Editors will notice:
- whether the review frames the field cleanly
- whether it evaluates disagreement honestly
- whether it pushes toward future questions and therapeutic meaning
- whether the paper reads like leadership, not literature cataloguing
4. Submit the package cleanly
The administrative package still matters:
- manuscript files
- figures and permissions where needed
- disclosures and author information
- cover note or explanatory communication to the editor
But for this journal, clean packaging is only the minimum threshold. It does not overcome weak editorial fit.
5. Editorial evaluation happens before real external momentum
At this stage, editors are deciding whether the article deserves deeper handling. They are not just checking for correctness. They are deciding whether the review belongs in this title specifically.
6. Peer review, if it happens, will focus on authority and synthesis
Reviewers are likely to test:
- whether the framing is balanced
- whether important conflicting evidence is addressed
- whether the clinical or therapeutic stakes are argued responsibly
- whether the article advances understanding rather than repackaging known literature
A realistic process table
Stage | What the journal is deciding | What usually creates friction |
|---|---|---|
Initial editorial look | Is this topic and author team right for Nature Reviews Cancer? | Narrow scope, weak authority, unclear urgency |
Concept or manuscript assessment | Does the piece synthesize the field at a high enough level? | Summary without critical integration |
Deeper editorial handling | Is this worth investing review bandwidth in? | Limited translational value or poor framing |
Peer review | Is the synthesis authoritative, balanced, and useful? | Missing competing models, weak future-direction logic |
Common mistakes and avoidable delays
- Treating the journal like a standard unsolicited review destination.
- Submitting a review that is really a narrow subtopic memo.
- Summarizing literature without making a clear conceptual argument.
- Ignoring therapeutic or clinical implications in a cancer review journal.
- Using a cover note that says little more than the abstract.
- Failing to explain why this piece belongs here instead of in a strong but less selective review journal.
Delay often comes from editorial hesitation, not mechanics. If the editor cannot quickly see why this specific review matters for the journal, the process slows before reviewers are even the main issue.
What editors and reviewers will notice first
The opening frame
Editors will immediately ask whether the article defines a major cancer question or therapeutic direction with enough clarity. If the opening feels diffuse, the whole package feels less serious.
The author position
This journal cares about whether the authors look credible to write the review. If the manuscript does not feel anchored in recognized expertise, the process becomes harder.
The synthesis depth
Nature Reviews Cancer is not looking for a reference list in paragraph form. Editors and reviewers want:
- competing models weighed honestly
- field disagreements made explicit
- clinical consequences discussed carefully
- future research directions stated with judgment
The translational logic
Even a mechanism-heavy review should tell the reader why the biology matters. If the review never gets to therapeutic relevance, biomarkers, disease strategy, or translational stakes, it often feels incomplete for this journal.
What a strong proposal or cover message usually does
The strongest proposal materials usually explain:
- the exact field gap the review will address
- why the topic is timely now
- why the authors are credible to lead the synthesis
- how the article will go beyond a standard review
- what readers will understand differently after reading it
That is much more persuasive than sending a generic note that says the topic is important.
What a realistic unsolicited route often looks like
Many authors approach this journal as though the process begins with a finished manuscript. In reality, the more realistic route often starts by deciding whether the idea itself is likely to interest the editors before investing heavily in the final full package.
For an unsolicited review concept, the practical questions are:
- is the field inflection point clear enough to justify a major review now
- does the article have obvious clinical, therapeutic, or translational stakes
- will the review help readers reorganize a field, not just catch up on it
- are the authors well placed to write it
If the answer to any of those is uncertain, the best decision may be to redirect the article to a strong oncology review journal with a more conventional unsolicited pathway.
That is not a defeat. It is usually a better submission decision than spending months polishing a package that never really matched the editorial bar here.
It also gives the author team a cleaner chance to publish while the synthesis is still timely, rather than losing momentum inside an overly ambitious targeting strategy.
What to do before you commit to this journal
Ask three blunt questions:
- Would this still feel ambitious enough if compared with the best recent reviews in Nature Reviews Cancer?
- Does the manuscript synthesize a field, or does it mainly report what happened in one subarea?
- Would a less invitation-driven journal be a more realistic and faster route for this article?
Those questions save more time than polishing the portal package.
- Nature Reviews Cancer journal information and author guidance from Nature.
- Nature portfolio information for review-journal submission expectations and article types.
- Manusights cluster pages on Nature Reviews Cancer fit, desk-rejection risk, and journal selection support.
Jump to key sections
Final step
Submitting to Nature Reviews Cancer?
Run the Free Readiness Scan to see score, top issues, and journal-fit signals before you submit.
Anthropic Privacy Partner. Zero-retention manuscript processing.
Need deeper scientific feedback? See Expert Review Options
Where to go next
Start here
Same journal, next question
Supporting reads
Conversion step
Submitting to Nature Reviews Cancer?
Anthropic Privacy Partner. Zero-retention manuscript processing.